The application for the production of flutamidazole, a new class 3.1 antibiotic of Enhua Pharmaceutical Co., Ltd. was accepted
-
Last Update: 2014-09-26
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
According to the public information, flutromazole is a new type of local imidazole antifungal drug with broad-spectrum antibacterial activity, which was developed by urich pharmaceutical company in Spain The drug is suitable for the infection of epidermis caused by Trichophyton flavum, Microsporum canis and Trichophyton flocculus It has a certain local anti-inflammatory activity, good tolerance, rare local irritation and allergy According to CFDA, at present, there are no domestic manufacturers or importers of the drug Besides Enhua pharmaceutical, Beijing Sihuan Kebao Pharmaceutical Co., Ltd and Dezhou Bosheng Pharmaceutical Co., Ltd have applied for the production of APIs or preparations Enhua Pharmaceutical Co., Ltd is a leading drug manufacturer in the field of central nervous system in China The company's product research and development mainly focuses on anesthetics, psychoactive and neurologic drugs.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
